Protagonist Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTGX and other ETFs, options, and stocks.About PTGX
Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943.
CEODinesh V. Patel
CEODinesh V. Patel
Employees126
Employees126
HeadquartersNewark, California
HeadquartersNewark, California
Founded2006
Founded2006
Employees126
Employees126
PTGX Key Statistics
Market cap5.63B
Market cap5.63B
Price-Earnings ratio138.00
Price-Earnings ratio138.00
Dividend yield—
Dividend yield—
Average volume1.10M
Average volume1.10M
High today$89.75
High today$89.75
Low today$87.27
Low today$87.27
Open price$87.27
Open price$87.27
Volume319.92K
Volume319.92K
52 Week high$96.54
52 Week high$96.54
52 Week low$33.70
52 Week low$33.70
Stock Snapshot
As of today, Protagonist Therapeutics(PTGX) shares are valued at $88.73. The company's market cap stands at 5.63B, with a P/E ratio of 138.00.
During the trading session on 2025-12-24, Protagonist Therapeutics(PTGX) shares reached a daily high of $89.75 and a low of $87.27. At a current price of $88.73, the stock is +1.7% higher than the low and still -1.1% under the high.
Trading volume for Protagonist Therapeutics(PTGX) stock has reached 319.92K, versus its average volume of 1.1M.
The stock's 52-week range extends from a low of $33.70 to a high of $96.54.
The stock's 52-week range extends from a low of $33.70 to a high of $96.54.
Analyst ratings
92%
of 13 ratingsBuy
92.3%
Hold
7.7%
Sell
0%
People also own
Based on the portfolios of people who own PTGX. This list is generated using Robinhood data, and it’s not a recommendation.